Featured Research

from universities, journals, and other organizations

Tibetans developed genes to help them adapt to life at high elevations

Date:
May 15, 2010
Source:
University of Utah Health Sciences
Summary:
Researchers have long wondered why the people of the Tibetan Highlands can live at elevations that cause some humans to become life-threateningly ill -- and a new study answers that mystery, in part, by showing that through thousands of years of natural selection, those hardy inhabitants of south-central Asia evolved 10 unique oxygen-processing genes that help them live in higher climes.

Tibetans at a temple at Gannan Tibetan Autonomous Prefecture.
Credit: iStockphoto

Researchers have long wondered why the people of the Tibetan Highlands can live at elevations that cause some humans to become life-threateningly ill -- and a new study answers that mystery, in part, by showing that through thousands of years of natural selection, those hardy inhabitants of south-central Asia evolved 10 unique oxygen-processing genes that help them live in higher climes.

In a study published May 13 in Science Express, researchers from the University of Utah School of Medicine and Qinghai University Medical School in the People's Republic of China report that thousands of years ago, Tibetan highlanders began to genetically adapt to prevent polycythemia (a process in which the body produces too many red blood cells in response to oxygen deprivation), as well as other health abnormalities such as swelling of the lungs and brain (edema) and hypertension of the lung vessels leading to eventual respiratory failure. Even at elevations of 14,000 feet above sea level or higher, where the atmosphere contains much less oxygen than at sea level, most Tibetans do not overproduce red blood cells and do not develop lung or brain complications. The Utah and Chinese researchers found evidence that this might be related to at least 10 genes, two of which are specific genes strongly associated with hemoglobin, a molecule that transports oxygen in the blood.

High-altitude lung and brain complications threaten and even kill mountaineers who scale the world's tallest peaks. Others who find themselves at elevations significantly higher than where they normally live and work also can be stricken with the condition. Adaptations to living at higher altitudes have occurred in humans more than once, such as with people indigenous to the Andes Mountains in South America and people native to high altitude regions in the Ethiopian mountains in Africa. But the Tibetans have evolved genes that others living at similar elevations have not developed, according to Lynn B. Jorde, Ph.D., professor and chair of human genetics at the U of U School of Medicine and a senior author on the study. "For the first time, we have genes that help explain that adaptation," Jorde said.

The study was undertaken after Josef T. Prchal, M.D., a hematologist and professor of internal medicine, approached Jorde about doing genetic analysis related to his research on polycythemia. "What's unique about Tibetans is they don't develop high red blood cells counts," said Prchal, also a senior author on the study who has done research in Tibet. "If we can understand this, we can develop therapies for human disease."

Prchal's request prompted Tatum S. Simonson, a doctoral student in Jorde's lab and first author on the study, to travel to Tibet to collect DNA from people who lived in the region. Working with Ge Re-li, M.D., Ph.D., director of the Research Center for High Altitude Medicine at Qinhai University Medical School in Xining, China, Simonson took blood samples from 75 people who live in a village 14,720 feet above sea level. After eliminating some samples because of kinship and other factors, she narrowed the blood sample selection to 31 -- large enough for statistical validity. These samples were analyzed for 1 million genetic mutations or single nucleotide polymorphisms (SNPs).

The U of U research group then made a list of 247 candidate genes related to processing oxygen or other physiological features potentially associated with Tibetans' ability to thrive in higher elevations.

Two post-doctoral fellows in Jorde's lab, Chad D. Huff, Ph.D., and David J. Witherspoon. Ph.D., and Simonson performed computer analyses to compare the DNA variants in the villagers' blood samples with those from people living at neighboring lower elevations regions. This helped identify genes in the Tibetans that were not found in nearby populations. From this analysis the researchers narrowed the number of candidate genes down to 10, including the two strongly related to hemoglobin.

Although much work remains, and there could be other physiological reasons for the Tibetans' ability to thrive at higher elevations, the researchers believe those 10 genes might have allowed the Tibetans to evolve more efficient metabolisms and not overproduce red blood cells in response to thinner air. The Tibetans also show higher levels of nitric oxide, a molecule that may help get more oxygen to tissues and prevent polycythemia.

"This might help make up for having fewer red blood cells," Jorde said.

A detailed understanding of these changes may eventually lead to targeted therapies for common human maladies, including pulmonary hypertension and lung and brain edema, which affect people everywhere.

Obtaining permission to conduct research in Tibet is difficult, and the U of U researchers say without the help of Re-Li, senior author on the study, the project may not have been possible.


Story Source:

The above story is based on materials provided by University of Utah Health Sciences. Note: Materials may be edited for content and length.


Journal Reference:

  1. enetic Evidence for High-Altitude Adaptation in Tibet Tatum S. Simonson, Yingzhong Yang, Chad D. Huff, Haixia Yun, Ga Qin, David J. Witherspoon, Zhenzhong Bai, Felipe R. Lorenzo, Jinchuan Xing, Lynn B. Jorde, Josef T. Prchal, and RiLi Ge. Genetic Evidence for High-Altitude Adaptation in Tibet. Science, 13 May 2010 DOI: 10.1126/science.1189406

Cite This Page:

University of Utah Health Sciences. "Tibetans developed genes to help them adapt to life at high elevations." ScienceDaily. ScienceDaily, 15 May 2010. <www.sciencedaily.com/releases/2010/05/100513143453.htm>.
University of Utah Health Sciences. (2010, May 15). Tibetans developed genes to help them adapt to life at high elevations. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/05/100513143453.htm
University of Utah Health Sciences. "Tibetans developed genes to help them adapt to life at high elevations." ScienceDaily. www.sciencedaily.com/releases/2010/05/100513143453.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins